|
Market Closed -
Bombay S.E.
10:02:27 03/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 8.750 INR | +6.58% |
|
+1.86% | -38.81% |
| 10-01 | Gennex Laboratories Limited Announces Board Changes | CI |
| 08-14 | Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 2.13B 22.44M 20.05M 18.42M 16.73M 31.41M 32.2M 220M 88.43M 1.12B 84.23M 82.43M 3.56B | P/E 2025 |
15.4x | P/E 2026 | 8.26x |
|---|---|---|---|---|---|
| Enterprise Value | 2.55B 26.87M 24.01M 22.05M 20.03M 37.61M 38.55M 263M 106M 1.34B 101M 98.7M 4.26B | EV / Sales 2025 |
1.79x | EV / Sales 2026 | 1.25x |
| Free-Float |
66.61% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +6.58% | ||
| 1 week | +1.86% | ||
| Current month | +9.10% | ||
| 1 month | -10.71% | ||
| 3 months | -1.24% | ||
| 6 months | -12.41% | ||
| Current year | -38.81% |
| 1 week | 7.7 | 9.21 | |
| 1 month | 7.7 | 10.25 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 16.3 | |
| 3 years | 7.05 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 17/05/2012 |
| Director of Finance/CFO | - | 11/11/2024 | |
| Compliance Officer | 62 | 19/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 20/12/2020 | |
| Director/Board Member | 62 | 30/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.58% | +1.86% | -46.74% | -21.31% | 21.07M | ||
| -0.26% | +9.71% | +56.87% | +147.69% | 1,257B | ||
| -1.73% | -1.05% | +42.77% | +75.71% | 651B | ||
| -1.19% | -0.38% | +34.61% | +101.75% | 510B | ||
| -1.56% | -2.01% | +50.67% | +64.81% | 388B | ||
| -2.76% | +1.33% | +74.22% | +39.01% | 366B | ||
| -0.02% | +2.11% | +32.16% | +57.79% | 303B | ||
| -0.72% | +7.32% | +11.29% | +33.98% | 288B | ||
| -0.81% | +2.96% | +55.66% | +70.91% | 252B | ||
| -1.46% | +5.90% | +38.03% | +106.47% | 211B | ||
| Average | -0.42% | +3.69% | +34.95% | +67.68% | 422.67B | |
| Weighted average by Cap. | -1.09% | +5.30% | +47.05% | +93.20% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.38B 14.56M 13.01M 11.95M 10.85M 20.38M 20.89M 143M 57.37M 728M 54.64M 53.47M 2.31B | 1.73B 18.24M 16.29M 14.96M 13.59M 25.52M 26.16M 179M 71.86M 912M 68.45M 66.98M 2.89B |
| Net income | 181M 1.91M 1.71M 1.57M 1.43M 2.68M 2.74M 18.74M 7.54M 95.65M 7.18M 7.03M 303M | 210M 2.21M 1.98M 1.82M 1.65M 3.1M 3.18M 21.69M 8.73M 111M 8.31M 8.13M 351M |
| Net Debt | -275M -2.9M -2.59M -2.38M -2.16M -4.06M -4.16M -28.41M -11.43M -145M -10.89M -10.65M -460M | 420M 4.43M 3.96M 3.63M 3.3M 6.2M 6.35M 43.38M 17.45M 221M 16.62M 16.27M 702M |
Employees
125
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/11/26 | ₹8.750 | +6.58% | 321,525 |
| 02/11/26 | ₹8.210 | +2.37% | 1,053,207 |
| 30/10/26 | ₹8.020 | -10.49% | 1,321,688 |
| 29/10/26 | ₹8.960 | -1.54% | 188,622 |
| 28/10/26 | ₹9.100 | +2.48% | 286,354 |
- Stock Market
- Stocks
- GENNEX6 Stock
Select your edition
All financial news and data tailored to specific country editions
















